Let's get phygital 2021: Transforming from biotech to biopharma

On-demand webinar

Let’s get phygital 2021: transforming from biotech to biopharma

Transforming from biotech to biopharma: creating a new value chain to serve unmet patient needs.

Discover how Galapagos’ supply chain acted as the backbone of their transformation from a biotech to a biopharma company.

By Wouter Keymeulen, VP Quality Galapagos, and Pieter Van den Meutter, Head of Customer Intelligence Bluecrux.

Let’s get phygital 2021